Thanks, Rohit. Good morning, everyone. We delivered another set of very strong results in the third quarter of 2024. GAAP net income was $181 million or $1.15 per diluted share compared to $1.02 per diluted share in the same period last year and $1.16 per diluted share in the second quarter of 2024. Return on equity was 15%. Adjusted operating income was $182 million or $1.16 per diluted share compared to $1.02 per diluted share in the same period last year and $1.27 per diluted share in the second quarter of 2024. Adjusted operating return on equity was 15%. Turning to revenue drivers, primary insurance in force increased to $268 billion in the third quarter, up $2 billion sequentially and up $6 billion or 2% year over year. New insurance written was approximately $14 billion, flat sequentially and down 6% year over year, primarily driven by lower estimated market share. Persistency was 83% in the third quarter, flat sequentially and down one percentage point year over year. The portfolio remains resilient to mortgage rate volatility, with 8% of the mortgages in our portfolio having rates at least 50 basis points above the October 31st mortgage rate. Additionally, 70% of our portfolio has a mortgage rate below 6%. With these facts and continued volatility in mortgage rates, we anticipate the elevated persistency will continue to help offset lower production in the current higher rate environment. Net premiums earned were $249 million, up $4 million or 2% sequentially and up $6 million or 2% year over year. The sequential and year-over-year increases in net premiums were driven by insurance in force growth and our growth in attractive adjacencies consisting primarily of InappRe's GSE CRT participation. These increases were partially offset by higher ceded premiums. Our base premium rate of 40.2 basis points was down 0.1 basis points sequentially and flat year over year. As a reminder, our base premium rate is relatively stable, though several factors tend to modestly impact fluctuations from quarter to quarter. Our net earned premium rate was 36.3 basis points, down 0.1 basis points sequentially as higher ceded premiums offset the increase in single premium cancellations. Investment income in the third quarter was $61 million, up $1 million or 2% sequentially, and up $6 million or 11% year over year. Elevated interest rates have increased our investment portfolio yields, and as our portfolio rolls over, we anticipate further yield improvement. During the quarter, our new money investment yield contributed to an overall portfolio book yield of 3.9%. Our focus remains on high-quality assets and maintaining a resilient A-rated portfolio. As we have previously stated, while we typically hold investments to maturity, we may selectively pursue income enhancement opportunities. This does not change our view that our investment portfolio's unrealized loss position is materially non-economic. Credit losses in the third quarter of 2024 were $12 million, and the loss ratio was 5%, compared to negative $17 million or negative 7%, respectively, in the second quarter of 2024 and $18 million and 7%, respectively, in the third quarter of 2023. Our losses and loss ratio increased sequentially, primarily driven by a lower reserve release in the current quarter and higher new delinquencies. Year over year, our losses and loss ratio in the current quarter decreased, primarily driven by continued favorable cure and loss mitigation activity, leading to a $65 million reserve release. This compares to reserve releases of $77 million and $55 million in the second quarter of 2024 and third quarter of 2023, respectively. As a reminder, last quarter, we lowered our claim rate expectations on both existing and new delinquencies from 10% to 9%, reflecting continued strong cure performance and our current market expectations. While remaining aligned with our measured and prudent approach to loss reserves, we maintained the 9% claim rate on new delinquencies for the third quarter. New delinquencies increased sequentially to 13,000 from 10,500. Our new delinquency rate for the quarter was 1.4%, reflective of ongoing positive credit trends driven by historical seasonality and the aging of our newer books as they go through their normal loss curves and seasonal patterns. During the quarter, we experienced a modest impact from Hurricane Barrel-related delinquencies but expect a more meaningful impact from Hurricanes Helene and Milton beginning in the fourth quarter. As a reminder, we have historically seen hurricane-related new delinquencies cure at a very high rate, as our policy requires the homes to be inhabitable before we pay a claim. Total delinquencies in the third quarter increased sequentially to 21,000 from 19,100 as new delinquencies outpaced cures. Cures, however, remain robust as our cure rate of 57% remains significantly elevated as compared to pre-pandemic levels. The primary delinquency rate for the quarter was 2.2% compared to 2% sequentially and year over year. Putting it all together, we believe credit performance remained strong in the quarter, bolstered by ongoing macroeconomic resiliency, quality underwriting, and strong embedded equity. Operating expenses in the third quarter of 2024 were $56 million, and the expense ratio was 22% compared to $56 million and 23%, respectively, in the second quarter of 2024 and $55 million and 23%, respectively, in the third quarter of 2023. The current quarter and second quarter of 2024 reflect expense actions taken, resulting in one-time expenses of $1 million and $3 million, respectively. As Rohit mentioned, we remain committed to disciplined expense management while also investing in our business to support growth. During the quarter, we invested in initiatives to further modernize our technology solutions. We expect our full-year expenses, excluding one-time charges, to fall within our guidance range of $220 to $225 million. We continue to operate from a strong capital and liquidity position, reinforced by our robust PMIERs efficiency and the continued successful execution of our diversified CRT program. As of September 30, 2024, our third-party CRT program provides $1.8 billion of PMIERs capital credit. Our PMIERs sufficiency was 173% or $2.2 billion above PMIERs requirements at the end of the third quarter. As a reminder, in the second quarter of 2024, we further strengthened our balance sheet through our $750 million debt offering, which was used to refinance our 2025 notes. The offering extended our maturities while also reducing our annualized interest expense by $2 million. Let me now turn to capital allocation. During the quarter, we paid approximately $29 million, or 18.5 cents per common share, as our quarterly dividend. Today, we announced the fourth-quarter dividend of 18.5 cents per common share, payable December 5th. Additionally, we continue to deliver on our share buyback program, repurchasing 2.1 million shares at a weighted average share price of $35.34, for an approximate total of $71 million in the quarter. In October, we repurchased an additional 0.8 million shares at a weighted average share price of $35.89, for an approximate total of $30 million. As of October 31, 2024, there was approximately $137 million remaining on our $250 million repurchase authorization. As Rohit noted, our total capital return to date in 2024 is $283 million, and we expect to be in the upper end of our full-year $300 to $350 million guidance provided last quarter, reflecting our continued strong performance and balance sheet. Overall, we are incredibly pleased with our performance to date. We believe we are well-positioned to close out 2024 on a strong note and will remain focused on prudently managing risk and expenses, maintaining a strong balance sheet, and driving solid returns for our shareholders. With that, I will turn the call back over to Rohit.